Viral screening before each cycle of assisted conception treatment is expensive and unnecessary: a survey of results from a UK inner city clinic
Authors:
- Litha PepasLPLitha Pepas
- Tarek el ToukhyTTTarek el Toukhy
- Yacoub KhalafYKYacoub Khalaf
- Peter BraudePBPeter Braude
- 17 November 2011
- journal article
- Published by Taylor & Francis in Human Fertility
- Vol. 14 (4) , 224-229
Abstract
The European Union Tissues and Cells Directive requires screening of tissue and cell donors for infective organisms to prevent inter-patient transmission. The Directive includes the unique term partner donation, which refers to "donation of reproductive cells between a man and a woman who declare that they have an intimate physical relationship". In line with the Directive, partners undergoing Assisted Reproductive Technology (ART) now require screening before each treatment, regardless of the time interval between consecutive cycles. Evidence to support this recommendation is lacking. Therefore, we conducted a retrospective study of all virology screening tests undertaken over a three year period for individuals attending an assisted conception unit serving a high risk inner city population. We ascertained prevalence and seroconversion rates for HIV, hepatitis B and C and estimated the additional cost of implementing the Directive fully in our unit. With more than 3910 ART individuals screened between January 2007 and December 2009, the prevalence of HIV, hepatitis B and C was 0.6, 1.7 and 0.4%, respectively. A total of 422 individuals had a second screening test during the three year period and none seroconverted. This study suggests that increasing the frequency of screening individuals undergoing ART to less than 12 months would not confer added benefit and has significant cost implications.Keywords
This publication has 9 references indexed in Scilit:
- Viral screening of couples undergoing partner donation in assisted reproduction with regard to EU Directives 2004/23/EC, 2006/17/EC and 2006/86/EC: what is the evidence for repeated screening?Human Reproduction, 2010
- Storage of cryopreserved reproductive tissues: evidence that cross-contamination of infectious agents is a negligible riskFertility and Sterility, 2010
- Establishing the safety profile of sperm washing followed by ART for the treatment of HIV discordant couples wishing to conceiveHuman Reproduction, 2007
- Medically assisted reproduction in the presence of chronic viral diseasesHuman Reproduction Update, 2004
- View 1: Assisted conception in couples with HIV infectionSexually Transmitted Infections, 2003
- Transmissions of hepatitis C virus during the ancillary procedures for assisted conception: Case reportHuman Reproduction, 2000
- Donor Insemination and Human Immunodeficiency Virus TransmissionObstetrics & Gynecology, 1998
- Hepatitis B transmission from contaminated cryopreservation tankThe Lancet, 1995
- The influence of contamination of culture medium with hepatitis B virus on the outcome of in vitro fertilization pregnanciesAmerican Journal of Obstetrics and Gynecology, 1991